{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T15:57:34Z","timestamp":1773763054628,"version":"3.50.1"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002794","name":"Swedish Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Centre for Innovative Medicine"},{"DOI":"10.13039\/501100007232","name":"Radiumhemmets Forskningsfonder","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007232","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Region Stockholm"},{"name":"South-Eastern Norway Regional Health"},{"name":"Authority","award":["2018092"],"award-info":[{"award-number":["2018092"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Withdrawal of nucleos(t)ide analogue (NUC) therapy in hepatitis B e antigen (HbeAg)-negative chronic hepatitis B (CHB) may lead to functional cure in a subset of patients. Although gut microbiota is known to influence both CHB progression and treatment outcomes, the oral microbiome in NUC cessation remains unexplored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This longitudinal study explored the oral microbiome in patients with CHB on NUC therapy &amp;gt; 2 years having a planned NUC cessation. Oral microbiome composition was analyzed in 110 saliva samples across 7 time points from 18 HBeAg-negative patients with 36 months follow-up. Favorable outcome was defined as either HBsAg loss or decline of &amp;gt; 1 log10 or sustained off-therapy HBV DNA level &amp;lt; 2000 IU\/mL during year 3. Hepatic flare was defined as alanine transaminase (ALT) &amp;gt; 80 U\/L or 2 \u00d7 baseline level.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The overall microbial composition remained stable during the study period. Patients with favorable outcome showed consistently higher alpha diversities (P &amp;lt; .001) from baseline, with lower intersample variations across all time points (P &amp;lt; .05), compared to unfavorable. Hepatitis B surface antigen (HBsAg), ALT, and aspartate transaminase (AST) correlated inversely with several Prevotella taxa and specific pathways (Spearman \u03c1 &amp;gt; \u22120.5, P &amp;lt; .01). Unfavorable outcome and high HBsAg level correlated with opportunistic taxa Haemophilus parainfluenzae and Porphyromonas catoniae. Random forest model incorporating validated microbial markers predicting favorable versus unfavorable outcome achieved higher predictive performance than clinical markers alone (area under curve, 0.79 vs 0.66).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our exploratory study suggests that oral microbiome profiling at NUC cessation in HBeAg-negative CHB could support prognostication of virological outcome.<\/jats:p>\n                    <jats:p>Clinical Trials Registration. NCT03681132.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/infdis\/jiaf591","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T13:13:24Z","timestamp":1763644404000},"page":"e630-e640","source":"Crossref","is-referenced-by-count":0,"title":["Oral Microbiome Diversity Matters on Nucleos(t)ide Analogue Cessation in Chronic Hepatitis B"],"prefix":"10.1093","volume":"233","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-5028-3482","authenticated-orcid":false,"given":"Mahin","family":"Ghorbani","sequence":"first","affiliation":[{"name":"Division of Pathology, Department of Laboratory Medicine, Karolinska Institutet , Huddinge ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0881-5551","authenticated-orcid":false,"given":"Agne","family":"Kvedaraite","sequence":"additional","affiliation":[{"name":"Division of Pathology, Department of Laboratory Medicine, Karolinska Institutet , Huddinge ,","place":["Sweden"]},{"name":"Folktandv\u00e5rden Stockholm ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0787-5849","authenticated-orcid":false,"given":"Khaled","family":"Al-Manei","sequence":"additional","affiliation":[{"name":"Division of Pathology, Department of Laboratory Medicine, Karolinska Institutet , Huddinge ,","place":["Sweden"]},{"name":"Division of Endodontics, Department of Restorative Dental Science, College of Dentistry, King Saud University , Riyadh ,","place":["Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Choon Boon","family":"Too","sequence":"additional","affiliation":[{"name":"Division of Pathology, Department of Laboratory Medicine, Karolinska Institutet , Huddinge ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Cederberg","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Karolinska University Hospital , Stockholm ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5966-7166","authenticated-orcid":false,"given":"Asgeir","family":"Johannessen","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Vestfold Hospital Trust , T\u00f8nsberg ,","place":["Norway"]},{"name":"Department of Infectious Diseases, Regional Advisory Unit for Imported and Tropical Diseases, Oslo University Hospital , Oslo ,","place":["Norway"]},{"name":"Faculty of Medicine, Institute of Clinical Medicine, University of Oslo , Oslo ,","place":["Norway"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dag Henrik","family":"Reikvam","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Regional Advisory Unit for Imported and Tropical Diseases, Oslo University Hospital , Oslo ,","place":["Norway"]},{"name":"Faculty of Medicine, Institute of Clinical Medicine, University of Oslo , Oslo ,","place":["Norway"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6771-7175","authenticated-orcid":false,"given":"Davide","family":"Valentini","sequence":"additional","affiliation":[{"name":"Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska University Hospital Huddinge and Karolinska Comprehensive Cancer Center , Stockholm ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Maucourant","sequence":"additional","affiliation":[{"name":"Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital , Huddinge ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0967-076X","authenticated-orcid":false,"given":"Niklas K","family":"Bj\u00f6rkstr\u00f6m","sequence":"additional","affiliation":[{"name":"Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital , Huddinge ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo","family":"Aleman","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Karolinska University Hospital , Stockholm ,","place":["Sweden"]},{"name":"Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital , Huddinge ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3793-4064","authenticated-orcid":false,"given":"Margaret","family":"S\u00e4llberg Chen","sequence":"additional","affiliation":[{"name":"Division of Pathology, Department of Laboratory Medicine, Karolinska Institutet , Huddinge ,","place":["Sweden"]},{"name":"Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska University Hospital Huddinge and Karolinska Comprehensive Cancer Center , Stockholm ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"key":"2026031710045262300_jiaf591-B1","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41575-023-00760-9","article-title":"Global burden of hepatitis B virus: current status, missed opportunities and a call for action","volume":"20","author":"Hsu","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2026031710045262300_jiaf591-B2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update","volume":"10","author":"Sarin","year":"2016","journal-title":"Hepatol Int"},{"key":"2026031710045262300_jiaf591-B3","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"key":"2026031710045262300_jiaf591-B4","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection","volume":"67","author":"Lampertico","year":"2017","journal-title":"J Hepatol"},{"key":"2026031710045262300_jiaf591-B5","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1053\/j.gastro.2018.10.027","article-title":"Factors associated with rates of HBsAg seroclearance in adults with chronic HBV infection: a systematic review and meta-analysis","volume":"156","author":"Yeo","year":"2019","journal-title":"Gastroenterology"},{"key":"2026031710045262300_jiaf591-B6","doi-asserted-by":"crossref","first-page":"6979","DOI":"10.12998\/wjcc.v9.i24.6979","article-title":"Discontinuation of antiviral therapy in chronic hepatitis B patients","volume":"9","author":"Medas","year":"2021","journal-title":"World J Clin Cases"},{"key":"2026031710045262300_jiaf591-B7","doi-asserted-by":"publisher","article-title":"Finite nucleos(t)ide analog therapy for functional cure in HBeAg-negative chronic hepatitis B: recent development in the paradigm shift","author":"Liaw","DOI":"10.1097\/HEP.0000000000001107"},{"key":"2026031710045262300_jiaf591-B8","first-page":"320","article-title":"Cessation of nucleoside\/nucleotide analogue therapy in chronic hepatitis B HBeAg-negative patients","volume":"18","author":"Pockros","year":"2022","journal-title":"Gastroenterol Hepatol"},{"key":"2026031710045262300_jiaf591-B9","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.jhep.2022.12.018","article-title":"A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B","volume":"78","author":"Van B\u00f6mmel","year":"2023","journal-title":"J Hepatol"},{"key":"2026031710045262300_jiaf591-B10","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jhep.2024.08.015","article-title":"Predictors of hepatic flares after nucleos(t)ide analogue cessation\u2014results of a global cohort study (RETRACT-B study)","volume":"82","author":"Dongelmans","year":"2025","journal-title":"J Hepatol"},{"key":"2026031710045262300_jiaf591-B11","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1038\/s41598-021-82538-0","article-title":"Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy","volume":"11","author":"Das","year":"2021","journal-title":"Sci Rep"},{"key":"2026031710045262300_jiaf591-B12","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3748\/wjg.v22.i2.501","article-title":"Gut microbiota imbalance and colorectal cancer","volume":"22","author":"Gagni\u00e8re","year":"2016","journal-title":"World J Gastroenterol"},{"key":"2026031710045262300_jiaf591-B13","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/microorganisms7010014","article-title":"What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases","volume":"7","author":"Rinninella","year":"2019","journal-title":"Microorganisms"},{"key":"2026031710045262300_jiaf591-B14","doi-asserted-by":"crossref","first-page":"105101","DOI":"10.1016\/j.ebiom.2024.105101","article-title":"Virological response to nucleos(t)ide analogues treatment in chronic hepatitis B patients is associated with Bacteroides-dominant gut microbiome","volume":"103","author":"Zhang","year":"2024","journal-title":"eBioMedicine"},{"key":"2026031710045262300_jiaf591-B15","doi-asserted-by":"crossref","first-page":"11773","DOI":"10.1038\/s41598-017-11779-9","article-title":"Variations in oral microbiota associated with oral cancer","volume":"7","author":"Zhao","year":"2017","journal-title":"Sci Rep"},{"key":"2026031710045262300_jiaf591-B16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature13568","article-title":"Alterations of the human gut microbiome in liver cirrhosis","volume":"513","author":"Qin","year":"2014","journal-title":"Nature"},{"key":"2026031710045262300_jiaf591-B17","doi-asserted-by":"crossref","first-page":"17098","DOI":"10.1038\/srep17098","article-title":"Decreased diversity of the oral microbiota of patients with hepatitis B virus-induced chronic liver disease: a pilot project","volume":"5","author":"Ling","year":"2015","journal-title":"Sci Rep"},{"key":"2026031710045262300_jiaf591-B18","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jhep.2024.09.046","article-title":"Oral-gut microbiome interactions in advanced cirrhosis: characterisation of pathogenic enterotypes and salivatypes, virulence factors and antimicrobial resistance","volume":"82","author":"Lee","year":"2025","journal-title":"J Hepatol"},{"key":"2026031710045262300_jiaf591-B19","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.jds.2024.08.016","article-title":"The salivary microbiome and oral health status in HBeAg-negative chronic hepatitis B","volume":"19","author":"Lu","year":"2024","journal-title":"J Dent Sci"},{"key":"2026031710045262300_jiaf591-B20","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1002\/hep.27819","article-title":"Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy","volume":"62","author":"Bajaj","year":"2015","journal-title":"Hepatology"},{"key":"2026031710045262300_jiaf591-B21","doi-asserted-by":"crossref","first-page":"e94416","DOI":"10.1172\/jci.insight.94416","article-title":"Microbiota, cirrhosis, and the emerging oral-gut-liver axis","volume":"2","author":"Acharya","year":"2017","journal-title":"JCI Insight"},{"key":"2026031710045262300_jiaf591-B22","doi-asserted-by":"publisher","article-title":"Salivary microbiome and serum metabolomics add to clinical biomarkers to predict 6-month hospitalizations in a multicenter cirrhosis outpatient cohort","author":"Bajaj","DOI":"10.1097\/HEP.0000000000001462"},{"key":"2026031710045262300_jiaf591-B23","doi-asserted-by":"crossref","first-page":"G824","DOI":"10.1152\/ajpgi.00230.2018","article-title":"Periodontal therapy favorably modulates the oral-gut-hepatic axis in cirrhosis","volume":"315","author":"Bajaj","year":"2018","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2026031710045262300_jiaf591-B24","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nri3785","article-title":"Periodontitis: from microbial immune subversion to systemic inflammation","volume":"15","author":"Hajishengallis","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"2026031710045262300_jiaf591-B25","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/apt.18147","article-title":"Clinical trial: an open-label, randomised trial of different re-start strategies after treatment withdrawal in HBeAg negative chronic hepatitis B","volume":"60","author":"Johannessen","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"2026031710045262300_jiaf591-B26","first-page":"137","article-title":"Salivary IgG to SARS-CoV-2 indicates seroconversion and correlates to serum neutralization in mRNA-vaccinated immunocompromised individuals","volume":"3","author":"Healy","year":"2022","journal-title":"Med N Y N"},{"key":"2026031710045262300_jiaf591-B27","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","article-title":"Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2","volume":"37","author":"Bolyen","year":"2019","journal-title":"Nat Biotechnol"},{"key":"2026031710045262300_jiaf591-B28","author":"Andrews"},{"key":"2026031710045262300_jiaf591-B29","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14806\/ej.17.1.200","article-title":"Cutadapt removes adapter sequences from high-throughput sequencing reads","volume":"17","author":"Martin","year":"2011","journal-title":"EMBnet J"},{"key":"2026031710045262300_jiaf591-B30","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nmeth.3869","article-title":"DADA2: high-resolution sample inference from Illumina amplicon data","volume":"13","author":"Callahan","year":"2016","journal-title":"Nat Methods"},{"issue":"Database issue","key":"2026031710045262300_jiaf591-B31","first-page":"D590","article-title":"The SILVA ribosomal RNA gene database project: improved data processing and web-based tools","volume":"41","author":"Quast","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"2026031710045262300_jiaf591-B32","author":"Oksanen","year":"2025"},{"key":"2026031710045262300_jiaf591-B33","doi-asserted-by":"crossref","first-page":"R60","DOI":"10.1186\/gb-2011-12-6-r60","article-title":"Metagenomic biomarker discovery and explanation","volume":"12","author":"Segata","year":"2011","journal-title":"Genome Biol"},{"key":"2026031710045262300_jiaf591-B34","first-page":"27663","article-title":"Analysis of composition of microbiomes: a novel method for studying microbial composition","volume":"26","author":"Mandal","year":"2015","journal-title":"Microb Ecol Health Dis"},{"key":"2026031710045262300_jiaf591-B35","doi-asserted-by":"crossref","first-page":"45477","DOI":"10.1038\/srep45477","article-title":"CombiROC: an interactive web tool for selecting accurate marker combinations of omics data","volume":"7","author":"Mazzara","year":"2017","journal-title":"Sci Rep"},{"key":"2026031710045262300_jiaf591-B36","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41587-020-0548-6","article-title":"PICRUSt2 for prediction of metagenome functions","volume":"38","author":"Douglas","year":"2020","journal-title":"Nat Biotechnol"},{"key":"2026031710045262300_jiaf591-B37","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.4959276","article-title":"A critical role of non-dysbiotic oral microbiota in mRNA Covid-19 vaccine effectiveness in immunocompromised individuals","author":"Ghorbani","journal-title":"Cell Press"},{"key":"2026031710045262300_jiaf591-B38","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1053\/j.gastro.2024.01.010","article-title":"The multi-dimensional challenge of poor oral health in cirrhosis\u2014disparities and solutions","volume":"166","author":"Lauridsen","year":"2024","journal-title":"Gastroenterology"},{"key":"2026031710045262300_jiaf591-B39","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s12072-025-10776-9","article-title":"Gut microbes associated with functional cure of chronic hepatitis B","volume":"19","author":"Honda","year":"2025","journal-title":"Hepatol Int"},{"key":"2026031710045262300_jiaf591-B40","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12866-020-01801-y","article-title":"Defining the oral microbiome by whole-genome sequencing and resistome analysis: the complexity of the healthy picture","volume":"20","author":"Caselli","year":"2020","journal-title":"BMC Microbiol"},{"key":"2026031710045262300_jiaf591-B41","doi-asserted-by":"crossref","first-page":"602239","DOI":"10.3389\/fcimb.2020.602239","article-title":"Salivary oral microbiome of children with juvenile idiopathic arthritis: a Norwegian cross-sectional study","volume":"10","author":"Frid","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"2026031710045262300_jiaf591-B42","doi-asserted-by":"crossref","first-page":"1936434","DOI":"10.1080\/20002297.2021.1936434","article-title":"Tongue microbiome in children with autism spectrum disorder","volume":"13","author":"Abdulhaq","year":"2021","journal-title":"J Oral Microbiol"},{"key":"2026031710045262300_jiaf591-B43","doi-asserted-by":"crossref","first-page":"112120","DOI":"10.1016\/j.celrep.2023.112120","article-title":"Periodontal disease is associated with increased gut colonization of pathogenic Haemophilus parainfluenzae in patients with Crohn's disease","volume":"42","author":"Sohn","year":"2023","journal-title":"Cell Rep"},{"key":"2026031710045262300_jiaf591-B44","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41522-025-00690-1","article-title":"Navigating complexities of polymorphic microbiomes in endometrial cancer","volume":"11","author":"Jimenez","year":"2025","journal-title":"NPJ Biofilms Microbiomes"},{"key":"2026031710045262300_jiaf591-B45","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1186\/s12864-024-10621-7","article-title":"Comparison between 16S rRNA and shotgun sequencing in colorectal cancer, advanced colorectal lesions, and healthy human gut microbiota","volume":"25","author":"Bars-Cortina","year":"2024","journal-title":"BMC Genomics"},{"key":"2026031710045262300_jiaf591-B46","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/JPER.20-0128","article-title":"Microbiome changes in young periodontitis patients treated with adjunctive metronidazole and amoxicillin","volume":"92","author":"Feres","year":"2021","journal-title":"J Periodontol"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiaf591\/65495755\/jiaf591.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/233\/3\/e630\/65495755\/jiaf591.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/233\/3\/e630\/65495755\/jiaf591.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T14:05:01Z","timestamp":1773756301000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/233\/3\/e630\/8342042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":46,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,12,2]]},"published-print":{"date-parts":[[2026,3,17]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiaf591","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3,15]]},"published":{"date-parts":[[2025,12,2]]}}}